Multiple Ascending Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of HSD-016 Administered Orally to Healthy Subjects.
Latest Information Update: 12 Dec 2009
Price :
$35 *
At a glance
- Drugs HSD 016 (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- 21 Jul 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 06 Mar 2009 New trial record